ACHV
Achieve Life Sciences IncNASDAQ
Healthcare • Biotechnology
Factor tilt: Small-Cap Blend
$6.72+5.41%
Close Nov 6, 2026
- Market cap
- $689.87M
- 1 month
- -6.5%
- 3 months
- +0.7%
- 1 year
- +36.3%
- 52-week range
- $2.65$8.53
- Dividend
- No payments on record
- Next-quarter EPS estimate
- -$0.19Quarter to Sep 30, 2026 · 12 analysts · -0.3% in 30d
- Short interest
- 23.8% of float17.8M shares · settled Oct 15, 2026 · +1.9% since Sep 30, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- —
- Net income
- -$114.04M
- Free cash flow
- -$47.04M
- Book value
- —
- Total debt
- $14.95M
- P/E
- —
- Price / sales
- —
- Price / book
- —
- FCF yield
- -6.8%
- Net margin
- —
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
About Achieve Life Sciences Inc
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms.
Read more
It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
- Website
- achievelifesciences.com
- Headquarters
- Bothell, WA, United States
- Employees
- 28
- Listed
- Oct 13, 1995
- Fiscal year ends
- December
Company profile from EODHD, stored Oct 27, 2026.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 11, 2026 | — | — | — | -$18.4M | -$74.8M |
| Mar 2026filed May 12, 2026 | — | — | — | -$10.5M | -$10.2M |
| Dec 2025filed Mar 24, 2026 | — | — | — | -$14.7M | -$14.7M |
| Sep 2025filed Nov 6, 2025 | — | — | — | -$14.7M | -$14.4M |
| Jun 2025filed Aug 7, 2025 | — | — | — | -$12.6M | -$12.7M |
| Mar 2025filed May 13, 2025 | — | — | — | -$12.9M | -$12.8M |
| Dec 2024filed Mar 11, 2025 | $228.0K | — | 50.0% | -$12.2M | -$12.4M |
| Sep 2024filed Nov 7, 2024 | — | — | — | -$12.5M | -$12.5M |
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Mar 24, 2026 | — | — | — | -$54.9M | -$54.6M |
| Dec 2024filed Mar 11, 2025 | — | — | — | -$39.1M | -$39.8M |
| Dec 2023filed Dec 31, 2023 | — | — | — | -$27.3M | -$29.8M |
| Dec 2022filed Mar 16, 2023 | — | — | — | -$40.8M | -$41.9M |
| Dec 2021filed Mar 10, 2022 | — | — | — | -$33.1M | -$32.9M |
| Dec 2020filed Mar 11, 2021 | — | — | — | -$14.8M | -$14.7M |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched ACHV. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
17,805,384 shares short
+331,276 shares (+1.9%) vs Sep 30, 2026
23.8% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
17,474,108 shares short
+1,480,294 shares (+9.3%) vs Sep 15, 2026
23.4% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
15,993,814 shares short
-453,831 shares (-2.8%) vs Aug 31, 2026
Share of float unavailable. Published Sep 24, 2026.
Settlement Aug 31, 2026
16,447,645 shares short
+32,195 shares (+0.2%) vs Aug 14, 2026
Share of float unavailable. Published Sep 10, 2026.
Settlement Aug 14, 2026
16,415,450 shares short
+142,042 shares (+0.9%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
16,273,408 shares short
+1,543,339 shares (+10.5%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind ACHV’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
1 for 20 · reverse split
Effective Jul 31, 2020
Each 20 pre-split shares become 1 post-split share.
Source: EODHD
1 for 10 · reverse split
Effective May 24, 2018
Each 10 pre-split shares become 1 post-split share.
Source: EODHD
1 for 11 · reverse split
Effective Aug 3, 2017
Each 11 pre-split shares become 1 post-split share.
Source: EODHD
1 for 18 · reverse split
Effective Aug 21, 2008
Each 18 pre-split shares become 1 post-split share.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if ACHV is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: MEDIUM
23 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Nov 3, 2026
Smart-money 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: neutral
Last trade: sell 78 days ago
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: neutral. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 0
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: neutral. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
112 filers reported a long position in ACHV for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
64.1%
of the 82.6M shares 13-F filers reported
Moves vs Q1 2026
5 added0 trimmed
5 new
Net shares held
+87.6%
across the 5 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | $49.7M · 7.6M shares | 7.6M | New |
| 2 | TPG GP A, LLC | $44.9M · 6.9M shares | 6.9M | New |
| 3 | venBio Partners LLC | $38.6M · 5.9M shares | 5.9M | New |
| 4 | Logos Global Management LP | $35.4M · 5.4M shares | 5.4M | New |
| 5 | BlackRock, Inc. | $34.4M · 5.3M shares | 5.3M | +1,099.9% |
| 6 | FRANKLIN RESOURCES INC | $32.3M · 5M shares | 5M | +13.4% |
| 7 | Paradigm Biocapital Advisors LP | $32.3M · 5M shares | 5M | New |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | $27M · 4.1M shares | 4.1M | +87.8% |
| 9 | Propel Bio Management, LLC | $26.3M · 4M shares | 4M | +6.5% |
| 10 | MARSHALL WACE, LLP | $24.6M · 3.8M shares | 3.8M | +269.9% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of ACHV file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Aug 17, 2026 | Logos Global Management LP13G · passive | 9.99% |
| Aug 13, 2026 | JANUS HENDERSON GROUP PLC13G · passive | 5.4% |
| Jul 28, 2026 | FRANKLIN RESOURCES INC13G · passive · amended | 8.3% |
| Jul 27, 2026 | BlackRock, Inc.13G · passive | 5.1% |
| Jul 8, 2026 | Vivo Opportunity Fund Holdings LP13G · passive | 5% |
| Apr 27, 2026 | CIK 202977713D · activist | 9.99% |
| Apr 24, 2026 | TPG GP A, LLC13D · activist | 12.6% |
| Apr 24, 2026 | Venrock Healthcare Capital Partners III LP13G · passive | 5.2% |
| Apr 24, 2026 | Frazier Life Sciences Public Fund LP13G · passive | 6.5% |
| Apr 24, 2026 | Paradigm Biocapital Advisors LP13G · passive | 9.2% |
Get the Full Analysis for ACHV
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.